Galmed Pharmaceuticals (GLMD) Interest Expenses (2014 - 2025)

Galmed Pharmaceuticals' Interest Expenses history runs 11 years deep, the most recent figure standing at -$4000.0 for Q3 2025.

• In Q3 2025, Interest Expenses changed N/A year-over-year to -$4000.0; the TTM figure through Dec 2025 stood at -$4000.0 (down 500.0% YoY), while the FY2021 annual figure was $6000.0, down 80.65% from the prior year.
• Interest Expenses was -$4000.0 for Q3 2025 at Galmed Pharmaceuticals, down from $1000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $9000.0 in Q3 2023 to a low of -$200000.0 in Q3 2022.
• Historically, Interest Expenses has averaged -$51750.0 across 4 years, with a median of -$8000.0 in 2022.
• Biggest YoY gain for Interest Expenses was 104.5% in 2023; the steepest drop was 1620.0% in 2023.
• A 4-year view of Interest Expenses shows it stood at -$200000.0 in 2022, then surged by 104.5% to $9000.0 in 2023, then sank by 88.89% to $1000.0 in 2024, then plunged by 500.0% to -$4000.0 in 2025.
• The last three Interest Expenses figures came in at -$4000.0 (Q3 2025), $1000.0 (Q1 2024), and $9000.0 (Q3 2023), per Business Quant data.